China’s Wuxi Healthcare Ventures leads $55m Series A in US-based LifeMine Therapeutics

Chinese investment firm Wuxi Healthcare Ventures has led a $55-million series A financing for US-based biotech company LifeMine Therapeutics after earlier investing in its $5 million seed round.

Continue reading this story with a subscription to DealStreetAsia.


Contact us for corporate subscriptions at